Oxaliplatin/Norcantharidin Prodrug Co-Loaded Nanoparticles: Synergistic DNA-Repair Blockade Plus PD-L1 Downregulation for Inhibit Tumor Growth and Metastasis.
- DOI
- 10.1002/adhm.202505173
- Published
- 2026 May
- Container
- Advanced healthcare materials
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/adhm.202505173,
title = {Oxaliplatin/Norcantharidin Prodrug Co-Loaded Nanoparticles: Synergistic DNA-Repair Blockade Plus PD-L1 Downregulation for Inhibit Tumor Growth and Metastasis.},
author = {Chen PW and Zhang YM and Li LS and Liu BB and Sun HL and Chen L and Yang X and Zhao MX},
year = {2026},
journal = {Advanced healthcare materials},
doi = {10.1002/adhm.202505173},
url = {https://doi.org/10.1002/adhm.202505173}
}RIS
TY - JOUR TI - Oxaliplatin/Norcantharidin Prodrug Co-Loaded Nanoparticles: Synergistic DNA-Repair Blockade Plus PD-L1 Downregulation for Inhibit Tumor Growth and Metastasis. AU - Chen PW AU - Zhang YM AU - Li LS AU - Liu BB AU - Sun HL AU - Chen L AU - Yang X AU - Zhao MX PY - 2026 JO - Advanced healthcare materials DO - 10.1002/adhm.202505173 UR - https://doi.org/10.1002/adhm.202505173 ER -
APA
PW, C., YM, Z., LS, L., BB, L., HL, S., L, C., X, Y., & MX, Z. (2026). Oxaliplatin/Norcantharidin Prodrug Co-Loaded Nanoparticles: Synergistic DNA-Repair Blockade Plus PD-L1 Downregulation for Inhibit Tumor Growth and Metastasis.. Advanced healthcare materials. https://doi.org/10.1002/adhm.202505173
Source records
- pubmed · retrieved 2026-09-26T02:19:55.572Z